AYTU BIOPHARMA INC (AYTU) Stock Analyst Ratings
USA - NASDAQ:AYTU - US0547548588 - Common Stock
2.36 USD
-0.15 (-5.98%)
ChartMill assigns a Buy % Consensus number of 82% to AYTU. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.35. This target is 296.19% above the current price.
AYTU was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AYTU.
In the previous month the buy percentage consensus was at a similar level.
AYTU was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-25 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-25 | Maxim Group | Maintains | Buy -> Buy |
| 2025-07-01 | Lake Street | Initiate | Buy |
| 2025-06-30 | Ascendiant Capital | Initiate | Buy |
| 2023-08-09 | Maxim Group | Initiate | Buy |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-07-21 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Cantor Fitzgerald | Maintains | Overweight |
| 2022-04-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-30 | Cantor Fitzgerald | Initiate | Overweight |